Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Levofloxacin/ketorolac trometamol - NTC

Next Previous
Search
Drug Profile

Levofloxacin/ketorolac trometamol - NTC

Alternative Names: NTC-014

Latest Information Update: 10 Feb 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator NTC
  • Class 2 ring heterocyclic compounds; Anti-infectives; Antibacterials; Carboxylic acids; Eye disorder therapies; Fluoroquinolones; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Pyrroles; Small molecules
  • Mechanism of Action Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 inhibitors; DNA gyrase inhibitors; DNA topoisomerase IV inhibitors; Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Infectious conjunctivitis

Highest Development Phases

  • Phase III Bacterial conjunctivitis

Most Recent Events

  • 10 Dec 2024 Phase-III clinical trials in Bacterial conjunctivitis (Ophthalmic) before December 2024 (NTC pipeline, December 2024)
  • 05 Dec 2024 NTC 014 is available for licensing in World as of 05 Dec 2024
  • 05 Dec 2024 Phase-II clinical trials in Bacterial conjunctivitis (In adults) (Ophthalmic) before December 2024

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top